))
OncoTalks are 10-15 minute educational podcasts featuring experts from The US Oncology Network, highlighting new treatments, indications and the latest advancements in oncology.
…
continue reading
In this podcast by Healio, host Shikha Jain, MD, FACP, covers modern day health care in an ever-evolving world. Through interviews with experts, Jain explores hot topics in oncology and beyond.
…
continue reading
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!
…
continue reading
The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results published in ASCO’s Journal of Clinical Oncology.
…
continue reading
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematolog ...
…
continue reading
Peer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.
…
continue reading
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and sta ...
…
continue reading
Featuring one-on-one discussions with leading oncology investigators, this series assists clinicians with the formulation of up-to-date clinical management strategies so that they can provide optimal care for patients with melanoma and nonmelanoma skin cancer.
…
continue reading
The Oncology Podcast including Supportive Care Matters by Dr. Bogda Koczwara, are brought to you by The Oncology Network. The Oncology Network are producers of digital resources that support busy oncology health professionals. For more information visit our website www.oncologynews.com.au. We also invite Healthcare Professionals to subscribe to The Oncology Newsletter and our Oncology Portal for free and exclusive resources at: www.oncologynetwork.com.au
…
continue reading
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
…
continue reading
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest ...
…
continue reading
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
All Talk Oncology is a Cancer Podcast that empowers cancer patients through insightful conversations that reinforces confidence and certainty about their cancer condition. Transforming a terrifying experience into a manageable one, by arming patients with the understanding they need, and the ability to take control of their treatments through knowledge, allowing effective interaction with their medical team.
…
continue reading
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
JCO's Award Winning podcast Cancer Stories: The Art of Oncology features stories, dialogue, and personal reflections that explore the experience of living with cancer or caring for people with cancer, hosted by Dr. Lidia Schapira.
…
continue reading
Designed for residents and fellows to provide an overview of the clinical practice and evidence behind management of each individual tumor site. Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, cancer
…
continue reading
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
…
continue reading
1
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
1
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
Rehabilitation Oncology is an indexed resource for the dissemination of peer-reviewed research-based evidence related to oncologic physical therapy and cancer rehabilitation. The journal provides a forum for scientific and professional exchange among researchers and practitioners throughout the world. The journal serves as the official journal for the Academy of Oncologic Physical Therapy. High standards of quality are maintained through a rigorous, double-blinded peer-review process and adh ...
…
continue reading
Oncology Information Group is a global resource for the latest updates in oncology advancements. Subscribe to our podcast to receive the latest updates as they become available.
…
continue reading
learn bite-sized information about different aspects of hematology and oncology.
…
continue reading
Oncology Congress provides US-based, practicing oncologists, nurses and pharmacists with the latest clinical data, best practices, and technology-driven innovations that directly enhance clinical practice and patient care.
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
An academic platform for discussion of the latest and greatest updates in the ever evolving field of Medical Oncology and Clinical Hematology. Contact prashant.jambunathan@gmail.com
…
continue reading
Outspoken Oncology, hosted by Chadi Nabhan, MD, MBA, FACP, is dedicated to facilitating candid discussion among all stakeholders on the most pressing—and often controversial—topics in cancer care today.
…
continue reading
Featuring one-on-one discussions with leading clinical investigators, this series bridges the gap between research and patient care by providing practicing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
…
continue reading
Fast Facts Oncology is a must listen for busy clinicians, allowing them to get quickly up-to-speed on the latest developments from the field.
…
continue reading
A podcast for uro-oncologists developing a deeper understanding of the literature to ensure we apply the right evidence to the right patient.
…
continue reading
Welcome to Integrative Oncology Talk! Where we discuss the latest science and opinions from leading voices in integrative oncology. Integrative oncology utilizes complementary therapies and lifestyle strategies to help those affected by cancer, using personalized approaches and evidence based recommendations. This podcast is hosted by Dr. Santosh Rao, a medical oncologist and integrative oncologist. Dr. Judith Lacey, a supportive care and integrative oncology physician. And Leigh Leibel (pro ...
…
continue reading
Hosted by Dr. Rick Ward, this podcast bridges the gap between primary care and oncology and links important information about cancer treatment to primary care doctors and their patients.
…
continue reading
1
Tenosynovial Giant Cell Tumor | Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor (Companion Faculty Lecture)
25:25
25:25
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
25:25
Featuring a slide presentation and related discussion from Dr Emanuela Palmerini, including the following topics: Background, diagnosis and disease course of tenosynovial giant cell tumor (TGCT) (0:00) Clinical data supporting systemic therapy for TGCT (10:19) Clinical data on emerging therapies for TGCT (17:28) Conclusion and future directions for…
…
continue reading
1
Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor
1:03:55
1:03:55
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:03:55
Dr Emanuela Palmerini from the IRCCS Istituto Ortopedico Rizzoli in Bologna, Italy, discusses the current and future clinical treatment of tenosynovial giant cell tumor.द्वारा Neil Love, MD
…
continue reading
1
Fuad El Rassi, MD, Modupe Idowu, MD - A New Script for SCD Care: Guidance on Patient-Centric Treatment Decisions With Innovative Therapeutics
1:23:59
1:23:59
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:23:59
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/EEY865. CME/AAPA c…
…
continue reading
1
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
18:46
18:46
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
18:46
Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib…
…
continue reading
1
The Data Behind Precision Medicine with Melody Harris
25:35
25:35
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
25:35
In this episode, host Shikha Jain, MD, speaks with Melody Harris about the evolution of precision medicine, what physicians and companies can do to help patients better understand precision oncology and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Harris 0:20 • The interview 1:11 • Tell us about how you ended up in…
…
continue reading
1
Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
56:12
56:12
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
56:12
Featuring perspectives from Dr Sarah B Goldberg, Dr Brad S Kahl, Dr Sagar Lonial, Dr Joyce O’Shaughnessy, Dr Noopur Raje, Dr Joshua K Sabari, Dr Matthew R Smith, Dr Sonali M Smith, Dr Sandy Srinivas and Dr Seth Wander, including the following topics: Introduction (0:00) Updates in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma — Dr Kahl (1:1…
…
continue reading
1
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
56:11
56:11
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
56:11
Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia.द्वारा Neil Love, MD
…
continue reading
1
Optimizing the Management of Tenosynovial Giant Cell Tumor
1:03:55
1:03:55
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:03:55
Dr Emanuela Palmerini from the IRCCS Istituto Ortopedico Rizzoli in Bologna, Italy, discusses the current and future clinical treatment of tenosynovial giant cell tumor, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.द्वारा Research To Practice
…
continue reading
1
FGFR-3 Inhibitor Has Early Clinical Activity in Advanced Urothelial Cancer
8:33
8:33
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
8:33
The fibroblast growth factor receptor-3 (FGFR-3) inhibitor TYRA-300 has been found safe with dose-dependent responses and disease control in the Phase I SURF301 trial. The study included 41 patients who had been heavily pre-treated for their advanced solid tumors with activating FGFR3 mutations/fusions, bringing the hope of avoiding toxicities from…
…
continue reading
1
Olympic Champion: From Gold Medals to Cancer Survivor | EP 62
57:05
57:05
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
57:05
What can an Olympic gold medalist teach us about facing cancer with resilience and grace? In this powerful episode, Shannon Miller, one of America's most decorated gymnasts, shares her journey from Olympic glory to battling a rare form of ovarian cancer. Her story reveals how the discipline and determination that earned her Olympic medals helped he…
…
continue reading
1
S1 Ep136: Collaboration Fosters Treatment Advancements for Young Lymphoma Populations
20:51
20:51
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
20:51
As part of Oncology On the Go, CancerNetwork® spoke with Andrew M. Evens, DO, MBA, MSc, about developments in the treatment landscape for adolescents and young adults (AYA) with lymphoma. He highlighted collaboration between adult and pediatric oncologists that may better standardize treatment for this population. Evens is the deputy director for c…
…
continue reading
In this OncoTalks episode, Dr. David Waterhouse and Dr. Paul Conkling discuss NSCLC and the groundbreaking developments in treating patients with METex 14 skipping mutations. We review the science behind these targeted therapies, their clinical applications, and the impact on patient outcomes. This episode offers vital information to help navigate …
…
continue reading
Host Dr. Davide Soldato and Dr. Aaron Mitchell discuss the JCO article "Quality of Treatment Selection for Medicare Beneficiaries With Cancer" TRANSCRIPT Dr. Davide Soldato: Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host,…
…
continue reading
1
To Help Oncologists’ Burnout, Should Primary Care Take on More Burden?
11:18
11:18
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
11:18
The European Society for Medical Oncology (ESMO) Resilience Task Force recently released recommendations intended to reduce burnout in oncology worldwide. One of the task force’s members, Konstantinos Kamposioras, MD, PhD, a consultant in medical oncology at the Christie NHS Foundation Trust in Manchester in the United Kingdom, explains to Robert A…
…
continue reading
1
Clinic Conversation of the Week: How to Talk to Patients About the BENEFIT Trial in Multiple Myeloma
5:36
5:36
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
5:36
The BENEFIT trial, which studied isatuximab, lenalidomide, dexamethasone, and bortezomib in transplant-ineligible multiple myeloma, was published earlier this year in Nature Medicine. I'll be talking about this as if it was one of my patients coming to me with a copy of this paper in their hand that a friend or loved one forwarded to them. What do …
…
continue reading
1
Let's Talk About Sex in Cancer Care
22:34
22:34
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
22:34
Send us a text Welcome to Episode 28 of The Oncology Podcast's Experts On Point series, brought to you by The Oncology Network. Hosted by Rachael Babin. Are you talking to your patients about sex enough? Research suggests that most healthcare professionals aren’t having these conversations as often as patients would like. Sexual health should be a …
…
continue reading
1
Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma
15:07
15:07
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
15:07
Dr Steven Horwitz (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a phase 1 study of valemetostat in relapsed or refractory non-Hodgkin lymphoma and a phase 2 study of valemetostat in relapsed or refractory peripheral T-cell lymphoma. Read the full Articles here: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(…
…
continue reading
1
In conversation with... Steven Horwitz
15:07
15:07
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
15:07
Dr Steven Horwitz (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a phase 1 study of valemetostat in relapsed or refractory non-Hodgkin lymphoma and a phase 2 study of valemetostat in relapsed or refractory peripheral T-cell lymphoma.द्वारा The Lancet
…
continue reading
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Erika Hamilton, MD The ELECTRA trial is seeking to evaluate the combination of elacestrant with abemaciclib in patients with ER+/HER2- metastatic breast cancer regardless of metastatic site and ESR1 status to see if this could be an all-oral treatment option before using fulvestrant-based combinations…
…
continue reading
1. Stage II Disease 2. Overview of BEP, EP, VIP 3. Advanced, refractory disease 4. Survivorship considerations Citations As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to y…
…
continue reading
